These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6299046)

  • 61. Treatment of hypertension with angiotensin converting enzyme inhibitors.
    Johnston CI; McGrath BP; Matthews PG; Jackson B
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():135-44. PubMed ID: 6183036
    [No Abstract]   [Full Text] [Related]  

  • 62. [Captopril inhibits angiotensin converting enzyme. New principles for therapy in hypertension and heart failure].
    Ohman KP; Karlberg BE
    Lakartidningen; 1981 Nov; 78(45):4039-41. PubMed ID: 6276631
    [No Abstract]   [Full Text] [Related]  

  • 63. Captopril: an oral angiotension converting enzyme inhibitor active in man.
    Brunner HR; Gavras H; Waeber B; Turini GA; Wauters JP
    Arch Int Pharmacodyn Ther; 1980; Suppl():188-212. PubMed ID: 6251762
    [No Abstract]   [Full Text] [Related]  

  • 64. Use of the oral angiotensin I--converting enzyme inhibitor (captopril) in childhood malignant hypertension.
    Oberfield SE; Case DB; Levine LS; Rapaport R; Rauh W; New MI
    J Pediatr; 1979 Oct; 95(4):641-4. PubMed ID: 383935
    [No Abstract]   [Full Text] [Related]  

  • 65. Introduction to the symposium on practical aspects of angiotensin-converting enzyme inhibition.
    Chilton RJ
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):164-5. PubMed ID: 3030976
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of captopril and aprotinin on inactive renin.
    Sealey JE; Overlack A; Laragh JH; Stumpe KO; Atlas SA
    J Clin Endocrinol Metab; 1981 Sep; 53(3):626-30. PubMed ID: 6167591
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Angiotensin converting enzyme inhibitors].
    Abe K
    Nihon Rinsho; 1985 May; 43(5):949-55. PubMed ID: 2993706
    [No Abstract]   [Full Text] [Related]  

  • 68. Captopril-induced changes in large arteries in essential hypertension.
    Simon AC; Levenson JA; Bouthier JL; Safar ME
    Am J Med; 1984 May; 76(5B):71-5. PubMed ID: 6328988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril.
    Textor SC; Bravo EL; Fouad FM; Tarazi RC
    Am J Med; 1982 Nov; 73(5):719-25. PubMed ID: 6291388
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical applications of angiotensin-converting enzyme inhibitors.
    Ferguson RK; Vlasses PH; Rotmensch HH
    Am J Med; 1984 Oct; 77(4):690-8. PubMed ID: 6091446
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Zinc metabolism during captopril treatment.
    Zumkley H; Bertram HP; Vetter H; Zidek W; Losse H
    Horm Metab Res; 1985 May; 17(5):256-8. PubMed ID: 3891571
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Successful acute and long-term treatment of renin-induced hypertension in two infants with captopril.
    Rosendahl W; Hayduk K
    Eur J Pediatr; 1980 Dec; 135(2):161-4. PubMed ID: 7004877
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Captopril in various forms of severe therapy-resistant hypertension.
    Studer A; Lüscher T; Siegenthaler W; Vetter W
    Klin Wochenschr; 1981 Jan; 59(2):59-67. PubMed ID: 6259406
    [No Abstract]   [Full Text] [Related]  

  • 74. Practical aspects of angiotensin-converting enzyme inhibition. Proceedings of a symposium. July 25 and 26, 1986, Denver, Colorado.
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):162-205. PubMed ID: 3030975
    [No Abstract]   [Full Text] [Related]  

  • 75. Therapeutic effect of captopril once-daily in essential hypertension.
    Gil V; Lahera V; Beneyto MC; Lopez-Vidriero E; Rodriguez FJ
    Bibl Cardiol; 1987; (42):152-5. PubMed ID: 2820374
    [No Abstract]   [Full Text] [Related]  

  • 76. Endocrine profile in the long-term phase of converting-enzyme inhibition.
    Swartz SL; Williams GH; Hollenberg NK; Crantz FR; Moore TJ; Levine L; Sasahara AA; Dluhy RG
    Clin Pharmacol Ther; 1980 Oct; 28(4):499-508. PubMed ID: 6250761
    [No Abstract]   [Full Text] [Related]  

  • 77. [The long term effect of the oral converting enzyme inhibitor captopril in hypertensive patients (author's transl)].
    Ogihara T; Maruyama A; Naka T; Mikami H; Hata T; Nakamaru M; Higaki J; Kanda T; Iwanaga K; Kumahara Y
    Nihon Naibunpi Gakkai Zasshi; 1980 Mar; 56(3):251-61. PubMed ID: 6245945
    [No Abstract]   [Full Text] [Related]  

  • 78. [Converting enzyme inhibitors in the treatment of essential hypertension].
    Sancho Rof J
    Med Clin (Barc); 1985 Nov; 85(14):578-80. PubMed ID: 3001445
    [No Abstract]   [Full Text] [Related]  

  • 79. Angiotensin-converting enzyme inhibition: a developing therapeutic concept. Introduction to session I: development.
    Gross F
    Am J Cardiol; 1982 Apr; 49(6):1384. PubMed ID: 6280471
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril.
    Ferguson RK; Vlasses PH
    Am Heart J; 1981 May; 101(5):650-6. PubMed ID: 6261570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.